CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
High ImpactOriginal article

STAT+: Lilly wins approval for once-weekly insulin shot

RegulatoryapprovedOnswikPositive
AI Analysis

Summary

The FDA approved Eli Lilly's Onswik, a once-weekly basal insulin for adults with type 2 diabetes, providing patients with an alternative to daily long-acting insulin injections.

Outcome Details

FDA approved once-weekly basal insulin for adults with type 2 diabetes

Importance:8/10
Sentiment:
0.85
FDA approvalinsulintype 2 diabetesonce-weekly
Related Companies

Read the original article

Published by STAT News on September 25, 2026 3:25 PM

Read Original